Novasecta carried out 20 in-depth private individual interviews with top executives from the European pharmaceutical industry.
You may also be interested in...
What Pharma Can Do About Brexit: Views From The C-Suite
London-based pharma consultancy Novasecta systematically researched the implications of the Brexit vote over the three-month period since the UK referendum vote in late June. The firm shares insights from its conversations with pharma company execs, and offers advice on managing in these uncertain times.